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Abstract 
Aim: The study investigated the rate of significant venous thromboembolism (VTE) 
following colorectal resection during the index admission and over one year following 
discharge. It identifies risk factors associated with VTE and considers the length of VTE 
prophylaxis required. 
Method: All adult patients who underwent colorectal resections in England between April 
2007 and March 2008 were identified using Hospital Episode Statistics (HES) data. They 
were studied during the index admission and followed for a year to identify any patients who 
were readmitted as an emergency with a diagnosis of deep venous thrombosis (DVT) or 
pulmonary embolism (PE).  
Results: 35997 patients underwent colorectal resection during the period of study. The VTE 
rate was 2.3%. Two hundred and one (0.56%) patients developed VTE during the index 
admission and 571 (1.72%) were readmitted with VTE. Following discharge from the index 
admission, the risk of VTE in patients with cancer remained elevated for six months 
compared with two months in patients with benign disease. Age, postoperative stay, cancer, 
emergency admission, and emergency surgery for patients with inflammatory bowel disease 
(IBD) were all independent risk factors associated with an increased risk of VTE. Patients 
with ischaemic heart disease and those having elective minimal access surgery (MAS) appear 
to have lower levels of VTE.  
Conclusion: This study adds to the benefits of MAS and demonstrates an additional risk to 
patients undergoing emergency surgery for IBD. The majority of VTE occurs following 
discharge from the index admission. Therefore, surgery for cancer, emergency surgery for 
IBD, and those with an extended hospital stay may benefit from extended VTE prophylaxis. 
This study demonstrates that a stratified approach may be required to reduce the incidence of 
VTE. 
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What does this paper add to the literature? 
The risk of VTE following colorectal surgery is very well known, but it is not clear from the 
literature how long the risk persists. This study shows the risk of VTE following discharge 
remains high for up to 6 months especially in patients having elective surgery for cancer and 
emergency surgery for IBD  
 
Introduction 
Venous thromboembolism (VTE) is a major cause of preventable morbidity and mortality. 
Each year around 25000-32000 patients die in the United Kingdom as a result of VTE related 
to hospital admission (1). The incidence of VTE in general surgical patients has been 
reported to be as high as 25% in patients who did not receive prophylaxis (2). An 
international consensus statement recommends that all moderate and high risk general 
surgery patients undergoing operation should receive VTE prophylaxis.(3) The National 
Institute for Health and Care Excellence (NICE) in England has issued guidelines that 
recommend VTE prophylaxis for all patients undergoing major abdominal surgery.(4, 5) 
Patients undergoing colorectal surgery are considered to be at high risk of VTE.(6-8) 
Certain factors such as cancer and major trauma are well known to increase the risk of 
VTE,(9, 10) but it is not clear whether emergency surgery with colonic resection is a risk 
factor. Although hospitalization without surgery is a risk factor for VTE,(11) there is little 
evidence to show that prolonged hospital stay following surgery increases the risk of VTE. 
Minimal access surgery (MAS) has been suggested to increase the risk of VTE following 
surgery (12, 13). The increased risk of VTE following MAS may be due to prolonged 
operating time, increased intra-abdominal pressure from pneumoperitoneum, and reverse 
Trendelenburg position.(14) Conversely MAS may reduce the risk of VTE because it is 
associated with a shorter hospital stay and early mobilization in the setting of enhanced 
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recovery. Recent studies suggest a lower risk of VTE following MAS compared to open 
colorectal surgery, (7, 15, 16) although these studies investigated the risk during the hospital 
admission but not following discharge.  
The risk of symptomatic VTE following surgery remains high following discharge. (17) In 
the case of bariatric surgery Steele et al showed the rate of cumulative VTE increases from 
0.88% during a hospital admission to 2.99% at 6 months post-surgery.(18)  Because the risk 
of VTE extends beyond the index hospital admission, recent studies(19) suggest that patients 
undergoing surgery for cancer should be discharged with 28 days of pharmacological VTE 
prophylaxis. NICE guidelines were modified in 2010 to recommend pharmacological VTE 
prophylaxis for 28 days postoperatively for patients having major cancer surgery involving 
the abdomen or pelvis.(5) 
The aim of this study was to investigate the rate of VTE following colorectal resection by 
laparoscopic or open technique for benign and malignant disease during the index admission 
and for one year following discharge. The study was also used to identify risk factors 
associated with VTE. 
 
Method 
Hospital Episodes Statistics (HES) data were obtained from the National Health Service 
Information Centre (NHSIC) and imported into Microsoft 2005 SQL server for analysis. All 
adult patients who underwent large bowel resection in England between April 2007 and 
March 2008 were identified by searching all operative fields of the HES dataset using Office 
of Population, Censuses and Surveys Classification of Surgical Operations and Procedures 
(4th revision) codes (OPCS-4). 
Patients undergoing laparoscopic repair were identified with the operative code Y75*, 
converted cases using Y714 and all other patients were considered open.  Pelvic surgery was 
defined as surgery involving the rectum and included anterior resection, abdominoperineal 
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resection, Hartmann’s operation (H33) and panproctocolectomy (H04), whereas other 
operations including total colectomy (H05 and H11), subtotal colectomy (H29), right 
hemicolectomy (H06 and H07), transverse colectomy (H08), left colectomy (H09) and 
sigmoid colectomy (H10) were classified as abdominal surgery.  
Patients with a malignant diagnosis of cancer were identified using the diagnostic codes ICD 
10 (C18 colon, C19 rectosigmoid, C20 rectum, and C21 anal canal), while all other diagnosis 
were classified as benign. Patients with benign pathology were subclassified into 
inflammatory bowel disease (IBD) using ICD10 codes (K50 for Crohn’s disease and K51 for 
ulcerative colitis) and other benign pathology. Patients were also classified according to 
surgical approach (minimal access surgery (MAS) versus open), mode of admission (elective 
versus emergency), gender, age, postoperative stay and co-morbidity.  
The mode of method was calculated by searching the admimeth (Admission Method) field 
which identifies how the patient was admitted to hospital (for elective admissions number 11, 
12, and 13were selected and 21, 22, 23, 24 for emergency admission). Comorbidity was 
identified by searching all secondary diagnostic fields for codes for ischaemic heart disease, 
congestive cardiac failure, hypertension, renal disease, metastatic disease, connective tissue 
diseases, dementia, diabetes mellitus and complications, chronic pulmonary disease, 
paraplegia and hemiplegia, liver disease, cerebrovascular accident and peripheral vascular 
disease. The codes used for comorbidity was obtained from the Dr Foster Charlson 
comorbidity score.(20) 
VTE was identified during the index admission i.e. an admission during which a patient 
underwent a colorectal resection using ICD-10 codes (International Classification Disease 
10th Edition) by searching the HES dataset for the codes for PE (I26*), DVT (I80.2) 
(thrombophelibitis of deep vessels of lower extremities), and I80.1 (thrombophelibitis of 
femoral vein) in any diagnostic field except the primary diagnosis.  
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To identify VTE occurring after the index admission, patients were then followed for a 
further year using HESID (the HES Patient ID (HESID) provides a way of tracking patients 
through the HES database without identifying them) to identify any who were readmitted to a 
hospital as emergency with a diagnosis of VTE in any of the first two diagnostic fields. Of 
course not all patients with VTE required admission, but most with a PE and suspected PE 
did so. Most hospitals also treat patients with extensive DVT, ileofemoral, or bilateral DVT, 
phlagmasia alba dolens, or phlagamsia cerulosa dolens as inpatients. Therefore, we define 
significant VTE as patients who presented to a hospital with VTE and required treatment as 
an inpatient.  A flow chart of the methodology is illustrated in Figure 1. 
 
Statistical analysis  
Univariate analysis including Chi square, Mann Whitney, and independent t-test were used as 
appropriate. Multivariate analysis was carried out with binary logistic regression.  Only 
factors that were statistically significant (P<0.05)   in univariate analysis were included in the 
multivariate analysis. All analyses were carried out using SPSS 13.  
 
 
Results 
35997 adult patients underwent colorectal resection between April 2007 and March 2008. 
The mean age was 65 years and the male to female ratio was 1:1. The median postoperative 
stay was 9 (IQR 6-15) days. Two thirds (66.3%) of the patients were admitted electively and 
one third as an emergency. The majority of patients (86%) underwent open surgery and 14% 
underwent MAS. More than half the procedures were performed for colorectal cancer (56%) 
and the rest were for benign pathology. A pelvic operation where surgery involved the rectum 
was performed in 42.7% of the patients and other types of colectomy were performed in 
57.3% of cases. 2710 patients (7.5%) died during the index admission.  
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
 201 (0.56%) patients were coded to have had VTE during the index admission, and 571 
(1.72%) were readmitted with VTE as the primary or secondary diagnosis as an emergency 
within a year of the index admission giving an overall rate of VTE at one year of 2.3%, most 
occurring in the first six months following surgery (Figure 2). 
 
Increasing age, prolonged postoperative stay, open surgery, cancer and emergency admission 
were all associated with an increased rate of VTE, whereas pelvic surgery and gender were 
not associated with higher rate of VTE (Table 1). 
Comorbidity including congestive cardiac failure, hypertension, and renal disease were 
associated with an increased risk of VTE. In contrast, patients with ischaemic heart disease 
appeared to have a lower rate of VTE (Table 2). 
 
Factors that were significantly associated with VTE on univariate analysis were included in 
the multivariate analysis (binary logistic regression). When the cohort was analysed as a 
whole, prolonged postoperative stay, increased age, emergency admission, and cancer were 
independent factors associated with a higher VTE rate whilst patients with ischaemic heart 
disease were less likely to develop VTE. All other factors including surgical approach were 
not associated with VTE as shown in Table 3. 
 
The proportion of patients admitted as an emergency that underwent MAS was small (10%) 
compared with open surgery. To eliminate any discrepancy between both groups due to the 
type of admission, the analysis was repeated for elective cases only.  This demonstrated that 
the surgical approach was an independent factor associated with increased risk of VTE in 
patients undergoing elective surgery. Open surgery increased the risk of VTE significantly 
compared with MAS with an odds ratio of 1.307 (1.008-1.693) as shown in Table 5. 
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The risk of a VTE was high during the index admission and for first few months following 
discharge. The risk of readmission with VTE following surgery for cancer remained high for 
six months following discharge, whereas the risk following surgery for benign disease 
reduced after two months (Figure 3). 
 
Patients who underwent surgery for cancer as an emergency had the highest rate of 
readmission for VTE, followed by patients who had elective surgery for cancer regardless of 
the period they spend in hospital following surgery during the index admission (Figure 4). 
The risk of readmission with VTE for patients who underwent surgery for benign pathology 
(whether elective or emergency) was low if the patients spent less than a week in the hospital 
whereas the risk increased significantly if they spent more than a week in the hospital.  
 
When benign pathology was subdivided into IBD and other benign disease, the former 
appeared to be associated with a higher rate of readmission with VTE compared with other 
benign disease (2.1% vs 1.7%). Most VTE in IBD patients occurred in patients who 
underwent emergency surgery as an (Figure 5). The length of hospital stay remained a major 
factor in readmission with VTE following discharge for all pathologies (cancer, IBD and 
benign) as shown in Figure 6. Multivariate analysis was performed for patients underwent 
emergency surgery for bowel resection and showed patients with IBD are significantly 
associated with VTE (P= 0.002 and OR 1.999 95%CI (1.353-2.952)) as shown in Table 6. 
 
Discussion  
This study showed that with a year’s follow up, the overall VTE rate in England in the year 
2007 to 2008 following colorectal surgery was 2.3%. The results from this study were very 
similar to those from previous publications.(21)  
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NICE guidelines for the prophylaxis of DVT were introduced in 2007 and then amended in 
2010 to recommend prolonged pharmacological prophylaxis in patients undergoing resection 
for malignancy.(22)  As we set out to examine the rates of VTE on the index admission and 
following discharge and since it was likely that the majority of colorectal resection patients 
with both benign and malignant disease had received in hospital pharmacological prophylaxis 
we chose to study the year 2007-2008 because prolonged pharmacological treatment in 
patients undergoing resection for malignancy was not yet in routine use. We cannot of course 
say what VTE prophylaxis this cohort of patients had, but we believe that the use of this time 
facilitated the comparison of the malignant and non-malignant groups. 
Only a quarter of patients coded as suffering a VTE were identified on the index admission. 
Further because there was no facility within HES to identify when a patient had suffered a 
VTE then some of the patients identified as having suffered a VTE on the index admission 
may have suffered this historically.  However, when coders found VTE in the past history 
taken at admission and they included it in the diagnostic code for completeness, they tended 
to use the 'Z (Personal history of...) Code'. Therefore, by searching for I codes only, we 
assumed only those with acute VTE were selected rather than those with a previous history of 
VTE. Another issue of the study was that other patients may have suffered a VTE many years 
previously that we could not identify by searching recent preceding years for an admission.  
We have therefore chosen to present the data in its unabridged form and acknowledge this as 
a concern, i.e. that the incidence of VTE on the index admission may be an overestimate. 
Two studies were recently published investigating the risk of VTE and surgery by linking 
HES data to primary care data. Humes et al(23) investigated the risk of VTE following 
colectomy but not rectal surgery and Bouras et al (24) investigated VTE rate following a 
number of operations including thyroid, breast, hernia, etc…. Both studies found similar 
results. The one year VTE rate was recorded to be 2.5% by the former study and the 90 days 
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VTE rate was 2.11% in the latter. Obesity is a known risk factor for VTE. Searching HES 
data for obesity codes is feasible, but we think it is significantly under recorded. Therefore, it 
was not included in the study. 
 
Most VTEs occur in patients who are readmitted during the year after the index admission. 
We have only included readmissions if the VTE code is in the first or second field making it 
much more likely that VTE was the reason for the readmission. Another limitation to the 
present study, was it only detected patients readmitted with VTE not those who developed it 
in the community or who were treated in an ambulatory setting without admission to hospital. 
The patients who were admitted to the hospital were, however, the high risk group. Patients 
with significant DVT (e.g. ileofemoral DVT, phlagmasia alba dolens, or phlagamsia cerulosa 
dolens) and most patients with acute PE or suspected PE were normally admitted to hospital 
and would have been be included and were at high risk of morbidity and mortality. 
 
Cancer and its treatment is a well-known risk factor for VTE(9) and it is no surprise that this 
study confirmed this finding. However, in addition, this study demonstrated that the risk of 
VTE remained elevated for at least six months following discharge.   
Prolonged post-operative hospital stay and increasing age were also associated with an 
increased risk of VTE which may have been due to poor mobility of patients especially in the 
elderly. Patients admitted as an emergency also had an increased risk of VTE and were likely 
to be sicker with poorer mobility and in a poor nutritional state compared with patients 
undergoing elective surgery. 
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When the full cohort of patients was analysed, binary logistic regression did not find any 
difference in the rate of VTE between patients undergoing MAS and open surgery. Most 
patients undergoing MAS were admitted electively, however, whereas a third of open 
surgical operations was performed following an emergency admission. The analysis was 
therefore repeated for all patients who were admitted electively. In this subgroup those 
undergoing MAS were shown to have a lower incidence of VTE than after open surgery.  
This may be an additional benefit of MAS over open surgery perhaps due in part to shorter 
hospital stay and early mobilization due to better pain control. 
 
Patients with ischaemic heart disease had a lower incidence of VTE (Odds ratio 0.520 and 
95% CI (0.351-0.769)). These patients are routinely started on antiplatelet medication or 
anticoagulation which may act as a protective factor against developing VTE postoperatively.  
 
The study has other limitations. It is a retrospective population based cohort study using data 
derived from Hospital Episode Statistics. HES are routinely collected by all hospitals in the 
NHS in England and the validity of the results therefore depends on the accuracy and depth 
of coding.  Nevertheless, previous studies have suggested that the accuracy of recording of 
diagnostic and operative codes in England is high,(25) but researchers still have to recognize 
and account for a degree of coding inaccuracy. HES has been shown to be useful for the 
assessment of effectiveness, comparative audit, and equity.(26) A recent systematic review 
showed that coding accuracy was improving and following the introduction of payment by 
result programme in 2002 the accuracy of primary diagnoses had increased from 73.8% 
(IQR: 59.3-92.1%) to 96.0% (IQR: 89.3-96.3).(27) Another limitation of this study is that 
data derived from HES cannot assess whether patients received VTE chemoprophylaxis and 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
for how long although by choosing the time point studied we have tried to reduce the effect 
of this confounding factor.  
In 2010 NICE recommended the use of subcutaneous heparin in patients with malignancy for 
28 days following discharge after surgical resection.(5) The study showed that only a quarter 
of patients who developed VTE did so during index admission and the risk of VTE remained 
high for six months following surgery. The four week period recommended may, therefore, 
not be adequate. Further studies to assess the risk of VTE following the introduction of NICE 
guideline 2010 may be useful to assess the effect of discharging patients with VTE receiving 
prophylaxis for 28 days. 
 
Patients with benign pathology had a lower rate of VTE than those for malignant disease; 
however in those with a prolonged stay, the rate of VTE was similar to those seen in patients 
with a diagnosis of cancer. We would suggest that patients with benign disease undergoing 
resection who have an inpatient stay for more than 15 days following surgery should 
therefore  also be considered for prolonged thromboprophylaxis following discharge. Perhaps 
the NICE guidelines should be amended to reflect this.  
Patients with IBD were at higher risk of developing VTE compared with healthy controls. 
(28) This study confirmed increased rates of VTE in IBD although elective surgery for IBD 
appeared to have a much lower rate of readmission with VTE compared with emergency 
surgery. This may in part be due to a prolonged hospital stay.  
 
VTE is a preventable condition, hence we believe every effort should be taken to reduce or 
eliminate the risk. The present study clearly demonstrated that a stratified approach may be 
needed to reduce the incidence of postoperative VTE in patients undergoing colorectal 
resection. Patients with a diagnosis of cancer and those undergoing colorectal resections for 
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benign condition with extended hospital stay including IBD may benefit from an extended 
period of chemoprophylaxis.  
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Factors  Total VTE  
Age mean (SD) 
VTE 67.1 years (11.9) 
<0.0001 
Non- VTE 64.5 years (15.6) 
Postoperative duration 
Median (IQR) 
VTE 12.5 days (8-23) 
<0.001 
Non- VTE 9 days (7-15) 
Gender 
Male 16989 367 (2.2%) 
NS 
Female 16330 405 (2.5% 
Surgical approach 
MAS 4982 85 (1.7%) 
0.003 
Open 28391 687 (2.4%) 
Diagnosis 
Benign 14273 280 (2.0%) 
<0.001 
Cancer 19046 492 (2.6%) 
Site of surgery 
Pelvic 14416 341 (2.4%) 
NS 
Abdominal 18903 431 (2.3%) 
Mode of admission 
Elective 23172 458 (2.0%) 
<0.001 
Emergency 10147 314 (3.1%) 
 
Table 1: Factors associated with increased risk of VTE (univariate analysis) 
SD = standard deviation, IQR = interquartile range, VTE = venous thromboembolism 
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Co-morbidity  Total (rate) VTE (rate) P value 
Ischaemic heart disease 
Yes 3352 (10%) 56 (1.7%) 
0.009 
No 29967 716 (2.4%) 
Cerebrovascular accident 
Yes 263 (0.8%) 8 (3%) 
NS 
No 33056 764 (2.3%) 
Congestive Cardiac Failure 
Yes 460 (1.4%) 18 (3.9%) 
0.022 
No 32859 754 (2.3%) 
Connective Tissue disorder 
Yes 423 (1.3%) 10 (2.4%) 
NS 
No 32869 762 (2.3%) 
Dementia 
Yes 144 (0.4%) 4 (2.8%) 
NS 
No 33175 768 (2.3%) 
Diabetes Mellitus 
Yes 3114 (9.4%) 63 (2%) 
NS 
No 30205 709 (2.3%) 
Liver disease 
Yes 487 (1.4%) 7 (1.4%) 
NS 
No 32832 765 (2.3%) 
Peripheral vascular disease 
Yes 675 (2.0%) 20 (3.0%) 
NS 
No 32644 752 (2.3%) 
Pulmonary diseases 
Yes 3393(10.2%) 83 (2.4%) 
NS 
No 29926 689 (2.3%) 
Paraplegia 
Yes 116 (0.4%) 5 (4.3%) 
NS 
No 33203 767 (2.3%) 
Renal disease 
Yes 740 (2.2%) 26 (3.5%) 
0.029 
No 32579 746 (2.3%) 
Metastatic disease 
Yes 3204 (9.6%) 97 (3.0%) 
0.005 
No 30115 675 (2.2%) 
Hypertension Yes 9352 (28.7%) 243 (2.6%) 0.033 
 
Table 2: Univariate analysis. Comorbidity and venous thromboembolism (VTE).  
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Factors Wald score P value OR (95% CI) 
Ischaemic heart disease 13.721 <0.001 0.587 (0.443-0.778) 
Congestive cardiac disease 2.390 NS 1.471 (0.902-2.401) 
Hypertension 1.766 NS 1.116 (0.949-1.313) 
Renal disease 0.135 NS 1.081 (0.714-1.636) 
Metastatic disease 1.806 NS 1.166 (0.932-1.460) 
Age 4.972 0.026 0.994 (0.988-0.999) 
Postoperative stay 43.665 <0.001 0.990 (0.987-0.993) 
Surgical approach MAS 2.520 NS 1 
Open 1.208 (0.957-1.524) 
Pathology Benign 20.066 <0.001 1 
Cancer 1.488 (1.251-1.771) 
Mode of admission Elective 35.731 <0.001 1 
Emergency 1.632 (1.390-1.971) 
 
Table 3: Multivariate analysis (binary logistics regression) of factors associated with VTE (all 
cases) 
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Factors MAS Open P value 
Age (Mean SD)Years 65.2 (50-80) 65.5 (50-80 NS 
Postoperative duration (Median IQR) 
Days 
7 (4-10) 10 (7-16) <0.001 
Pathology 
Cancer 66.2% 54.3% 
<0.001 
Benign 33.8% 45.7% 
Gender 
Male 50.8% 50.9% 
NS 
Female 49.5% 49.1% 
Site of surgery 
Pelvic 40.9% 43.0% 
0.004 
Abdomen 59.1% 57.0% 
Mode of admission 
Elective 90.0% 62.5% 
<0.001 
Emergency 10.0% 37.5% 
 
Table 4: Characteristics of minimal access surgery (MAS) compared with open surgery 
 
Factors Wald score P value OR (95% CI) 
Ischaemic heart disease 10.722 <0.001 0.520 (0.351-0.769) 
Congestive cardiac disease 1.118 NS 0.536 (1.70-1.698) 
Hypertension 0.241 NS 1.054 (0.855-1.300) 
Renal disease 0.412 NS 1.237 (0.646-2.367) 
Metastatic disease 5.803 0.016 1.394 (1.064-1.827) 
Age 1.379 NS 0.995 (0.988-1.003) 
Postoperative stay 21.141 <0.001 0.990 (0.986-0.994) 
Surgical approach MAS 4.086 0.043 1 
Open 1.307 (1.008-1.693) 
Pathology Benign 8.135 0.004 1 
Cancer 1.412 (1.114-1.789) 
Table 5: Multivariate analysis (binary logistics regression) of factors associated with VTE 
(elective cases only) 
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Factors Wald score P value OR (95% CI) 
Ischaemic heart disease 7.642 0.006 0.451 (0.257-0.793 
Congestive cardiac disease 0.092 NS 1.424 (0.944-2.147) 
Hypertension 2.722 NS 0.804 (0.621-1.042) 
Renal disease 0.003 NS 0.984 (0.572-1.693) 
Metastatic disease 1.452 NS 1.278 (0.858-1.904) 
Age 5.586 0.018 1.010 (1.002-1.019) 
Postoperative stay 21.718 <0.001 1.005-1.013) 
Surgical approach MAS 0.405 NS 1 
Open 1.245 (0.743-2.088) 
Pathology Benign 32.384 <0.001 1 
IBD 1.999 (1.353-2.952) 
Cancer 2.111 (1.608-2.771) 
 
Table 6: Multivariate analysis (binary logistics regression) of factors associated with VTE 
(emergency cases only) 
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Figure 1: Flow chart of steps used in analysis of data 
HESID = Hospital Episode  Statistics Patient Identification 
 
 
  
HES data April 2007-March 2009
Identify all patients undergoing colorectal 
resection April 2007 - March 2008
Identify mode of surgery by searching operative 
fields
Idenitfy pelvic or abdominal surgery by searching 
operative fields 
Identify pathology by searching the diagnostic 
fields
Identify method of admission by searching 
Admimeth
Identify all comorbidty factors by searching all 
secondary diagnostic fields
Identify VTE during index admission by 
searching all secondary diagnostic fields
Index cohort of patients ready for linking
Exclude any duplicate 
cases
Exclude children under 
age of 18
Identify all patients admited with VTE between 
April 2007 and March 2009
Identify all emergency admission with VTE
All patients with VTE ready for linking
index cohort patients were linked with 
VTE cohort using HESID. The time scale 
was set at 1 year between admisison date 
of index admission and readmission date 
with VTE
Exclude elective 
admission
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Figure 2: Interval between discharge from index admission to VTE (all cases) 
 
 
Figure 3: Interval between discharge from index admission to VTE of patients with cancer 
and benign pathology 
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Figure 6: Readmission rate with VT
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